E-ISSN 2534-9821
 
2023, Vol: 7, Issue: 6
7 / 6Current Issue Online FirstArchiveAims and ScopeAbstracting & IndexingMost Accessed ArticlesMost Downloaded ArticlesMost Cited Articles
Required files to be uploaded

Copyright Transfer Form

Original Research

Online Publishing Date:
16 / 05 / 2023

 


Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD

Amrita G, Aashay Dharia, Ajay Ashok Gujar.


Abstract
Prostaglandins are potent vasoactive agents with wide variety of other actions - vasodilatation, fibrinolysis and inhibition of platelet aggregation. Prostaglandin E1( PGE1) was the agent used since 1973 for cardiovascular diseases, mainly in patients with advanced peripheral vascular disease. PGE1 intra venous infusion has shown to be beneficial in limb threatening ischemia, especially when reconstructive procedures are not feasible. The original research of benefitted 28 cases in last 5 years is presented here.

Key words: : Extremities rest pain, ischemic ulcer, peripheral vascular disease, intravenous prostaglandin infusion


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Amrita G
Articles by Aashay Dharia
Articles by Ajay Ashok Gujar
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

G A, Dharia A, Gujar AA, . Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. Int J Med Rev Case Rep. 2023; 7(6): 43-46. doi:10.5455/IJMRCR.172-1654104544

Web Style

G A, Dharia A, Gujar AA, . Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. https://www.mdpub.net/?mno=46328 [Access: April 04, 2024]. doi:10.5455/IJMRCR.172-1654104544

AMA (American Medical Association) Style

G A, Dharia A, Gujar AA, . Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. Int J Med Rev Case Rep. 2023; 7(6): 43-46. doi:10.5455/IJMRCR.172-1654104544


Vancouver/ICMJE Style

G A, Dharia A, Gujar AA, . Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. Int J Med Rev Case Rep. (2023), [cited April 04, 2024]; 7(6): 43-46. doi:10.5455/IJMRCR.172-1654104544


Harvard Style

G, A., Dharia, A., Gujar, A. A. & (2023) Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. Int J Med Rev Case Rep, 7 (6), 43-46. doi:10.5455/IJMRCR.172-1654104544


Turabian Style

G, Amrita, Aashay Dharia, Ajay Ashok Gujar, and . 2023. Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. International Journal of Medical Reviews and Case Reports, 7 (6), 43-46. doi:10.5455/IJMRCR.172-1654104544


Chicago Style

G, Amrita, Aashay Dharia, Ajay Ashok Gujar, and . "Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD." International Journal of Medical Reviews and Case Reports 7 (2023), 43-46. doi:10.5455/IJMRCR.172-1654104544


MLA (The Modern Language Association) Style

G, Amrita, Aashay Dharia, Ajay Ashok Gujar, and . "Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD." International Journal of Medical Reviews and Case Reports 7.6 (2023), 43-46. Print. doi:10.5455/IJMRCR.172-1654104544


APA (American Psychological Association) Style

G, A., Dharia, A., Gujar, A. A. & (2023) Experience of Intravenous infusion of prostaglandin E1 for cessation of rest pain and further ischemic changes in patients with PVD. International Journal of Medical Reviews and Case Reports, 7 (6), 43-46. doi:10.5455/IJMRCR.172-1654104544


Author LoginReviewer LoginAbout PublisherEditorial PoliciesEditorial Review PolicyPeer Review PolicyEditorial & Peer Review ProcessAuthor's Rights and ObligationsPublication Ethics and Publication Malpractice StatementConflict of Interest PolicyPlagiarism PolicyProtection of Research Participants (Statement On Human And Animal Rights)Privacy PolicyCorrections, Retractions & Expressions of ConcernSelf-Archiving PoliciesDigital Archiving & Preservation PoliciesStatement of Informed ConsentAdvertising PolicyTerms of UseLicense InformationCopyright Information

About International Journal of Medical Reviews and Case Reports

International Journal of Medical Reviews and Case Reports  (Int J Med Rev Case Rep)ISSN: 2534-9821The International Journal of Medical Reviews and Ca ... Read more.



For best results, please use Internet Explorer or Google Chrome.

Contact Information


Any correspondence, queries or additional requests for information on the manuscript submission process should be sent to the International Journal of Medical Reviews and Case Reports editorial office as follows:

Bulgarian Association of Young Surgeons (BAYS);

National Center of Public Health and Analyses (NCPHA), floor 2, office № 31,  Sofia 1431, Bulgaria.

inkov@journalmedica.com

Financial department is managed by International Sci Ink Press. 

It is a company registered in Bulgaria with registered no. 205414288 and registered address at 57 Antim I str., Vazrazhdane, Sofia, 1303, Bulgaria.

Tel: +359883427500